An Aerosol is a tiny solid particle or liquid droplet suspension in air or some other gas. Aerosols can be both natural and man-made. Natural aerosols include fog or mists, dust, forestry exudates, and geyser steam. Particulate air pollution, mist from hydroelectric dam discharge, irrigated mist, perfumes from atomizers, smoking, steam from a kettle, sprayed insecticides, and medical interventions for respiratory disorders are all examples of anthropogenic aerosols. An anthropogenic aerosol is inhaled whenever a person breathes the contents of a vape pen or e-cigarette. Aerosol particles are generally smaller than 1 m in diameter. Aerosol concentration may be measured in a number of ways. The mass concentration (M), defined as the mass of particulate matter per unit volume and expressed in units such as g/m3, is frequently used in environmental research and environmental health. The number concentration (N) is another term for the number of particles per unit volume, which is measured in measures such as number per m3 or number per cm3. The aerosol particle radius or diameter (dp) is an important parameter used to characterise aerosols. Aerosol dispersion varies. A monodisperse aerosol, which may be created in the lab, comprises uniformly sized particles. However, most aerosols, being polydisperse colloidal systems, have a wide range of particle sizes.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia